Pharmacoepidemiology

Pharmacoepidemiology, as an interdisciplinary domain amalgamating pharmacology and epidemiology, is dedicated to scrutinizing the real-world ramifications of pharmaceuticals within populations. Employing observational research methodologies and scrutinizing extensive datasets, pharmacoepidemiologists discern intricate patterns concerning drug employment, adverse effects, and therapeutic consequences. A pivotal objective is the provision of evidence-based insights tailored for healthcare practitioners, policymakers, and the pharmaceutical sector. This, in turn, shapes decisions regarding drug prescription practices, regulatory measures, and public health strategies. Pharmacoepidemiological inquiries incorporate diverse study designs, encompassing cohort studies and case-control analyses, to meticulously explore outcomes related to drug usage.

The field continually evolves to surmount challenges inherent in addressing confounding variables and biases during the phases of data collection, analysis, and interpretation. The accrued insights play a pivotal role in the continual refinement of clinical guidelines and the vigilance inherent in drug safety monitoring protocols.

Committee Members
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd, United Kingdom

Submit your abstract Today

Youtube
Watsapp